Online Professional Master’s Degree in Cardio-Oncology
Overview
The Professional Master’s Degree in Cardio-Oncology is a comprehensive program for medical professionals specializing in the intersection of cardiovascular disease and oncology. It covers the latest advancements in cardio-oncology, focusing on cardiotoxicity management, early detection, and effective treatment strategies. The program is designed for cardiologists, oncologists, and hematologists who wish to deepen their expertise and enhance patient care in this critical field.
Key Features
100% Online Delivery: Study flexibly from anywhere in the world.
In-Depth Curriculum: Comprehensive coverage of cardiotoxicity, oncologic treatments, risk assessment, early detection, and management strategies.
Interactive Learning: Includes multimedia content, case studies, and practical workshops.
Accreditation: Accredited by GMC UK and NHS UK.
Free Certificate Delivery: Certificate delivered to your home, including international delivery.
No Mention of Online Study on Certificate: The certificate you receive will not indicate that the course was conducted online.
International Enrollment: Open to medical professionals globally.
International Recognition: Yes, allows foreign doctors to work in the UK without the need to pass the PLAB exams.
Technical Hours
Total Study Hours: Approximately 600 hours
Duration and Structure
Program Duration: 12 months
Delivery Mode: 100% online
ECTS Credits: 60
Price
Full Fee: GBP 2000
Eligibility
Educational Qualification: Medical degree (MBBS or equivalent)
Professional Experience: Beneficial but not mandatory
International Candidates: Open to medical professionals from all countries
General Objectives
Advanced Knowledge: Understand cardiotoxicity related to oncological treatments.
Early Detection: Utilize advanced diagnostic tools for early detection.
Effective Management: Manage cardiovascular complications in cancer patients.
Risk Assessment: Assess and manage risk factors for cardiotoxicity.
Multidisciplinary Approach: Integrate cardiology, oncology, and hematology insights.
Patient-Centered Care: Provide comprehensive care for cancer patients with cardiovascular issues.
Module Descriptions and Skills
Module 1: Epidemiology of Cancer
1.1. Epidemiological Significance of Cancer: Overview of cancer epidemiology, including incidence and outcomes.
Skills: Analyze cancer epidemiological data; understand cancer incidence trends.
1.2. Epidemiological Significance of Cardiotoxicity in Oncology: Impact of cancer treatments on cardiovascular health.
Skills: Assess the epidemiological impact of cardiotoxicity; correlate cancer treatments with cardiovascular outcomes.
1.3. Epidemiological Significance of Cardiotoxicity in Hematology: Risks associated with hematological malignancies.
Skills: Evaluate epidemiological risks of cardiotoxicity in hematological cancers; apply knowledge to risk management.
Module 2: Oncologic Treatments with Cardiotoxic Effect
2.1. Definition of Cardiotoxicity: Mechanisms and definitions.
Skills: Define cardiotoxicity; understand underlying mechanisms.
2.2. Radiotherapy as a Cause of Cardiotoxicity: Impact on cardiovascular health.
Skills: Evaluate the cardiovascular effects of radiotherapy; implement strategies to mitigate risks.
2.3. Chemotherapy as a Cause of Cardiotoxicity: Cardiovascular side effects of chemotherapeutic agents.
Skills: Identify cardiovascular side effects of chemotherapy; develop management plans.
2.4. Biological Agents as a Cause of Cardiotoxicity: Effects of targeted biological therapies.
Skills: Assess the impact of biological agents on cardiovascular health; devise intervention strategies.
2.5. Other Potentially Cardiotoxic Biological Agents: Additional agents and their effects.
Skills: Recognize lesser-known cardiotoxic biological agents; integrate findings into patient care.
2.6. Therapies Aimed at New Molecular Targets and Cardiotoxicity: Risks associated with new molecular-targeted therapies.
Skills: Analyze the cardiotoxic risks of emerging molecular therapies; adapt treatment plans accordingly.
2.7. Other Potentially Cardiotoxic Oncologic Treatments: Review of less common treatments.
Skills: Identify and manage risks associated with less common oncologic treatments.
Module 3: Comprehensive Assessment of the Risk of Cardiotoxicity Development
3.1. Individual Susceptibility to Cardiotoxicity: Genetic Factors: Genetic predispositions.
Skills: Interpret genetic risk factors for cardiotoxicity; incorporate genetic information into risk assessment.
3.2. Individual Susceptibility to Cardiotoxicity: Non-Genetic Factors: Lifestyle and environmental influences.
Skills: Assess non-genetic risk factors; apply lifestyle and environmental data to risk management.
3.3. Cardiological Assessment before Treatment in Patients without Known Heart Disease: Protocols for pre-treatment assessment.
Skills: Conduct comprehensive pre-treatment cardiological assessments; establish baseline cardiovascular health.
3.4. Cardiological Assessment before Treatment in Patients with Known Heart Disease: Management strategies for patients with pre-existing conditions.
Skills: Develop management strategies for patients with pre-existing heart disease; tailor assessments to individual needs.
3.5. Monitoring during Treatment of Patients Subjected to Cardiotoxic Treatments: Techniques for monitoring cardiovascular health.
Skills: Implement monitoring protocols; utilize diagnostic tools to track cardiovascular health during treatment.
Module 4: Early Detection of Cardiotoxicity
4.1. Circulating Biomarkers: Troponins: Role in early detection.
Skills: Utilize troponins for early detection of cardiotoxicity; interpret biomarker results.
4.2. Circulating Biomarkers: Natriuretic Peptides: Use in monitoring heart failure.
Skills: Apply natriuretic peptides in monitoring; integrate biomarker data into patient care.
4.3. Other Circulating Biomarkers for Early Detection: Additional biomarkers.
Skills: Identify and use other biomarkers for early detection; interpret results in the context of cardiotoxicity.
4.4. Echocardiography: Application in detecting heart function changes.
Skills: Perform echocardiographic assessments; detect and analyze heart function changes.
4.5. Cardiovascular Magnetic Resonance Imaging: Use of MRI in assessing myocardial damage.
Skills: Conduct and interpret MRI scans; assess myocardial damage and implications.
4.6. Computerized Axial Tomography: Role in evaluating cardiovascular complications.
Skills: Utilize CT scans for cardiovascular evaluation; interpret results in the context of oncology.
Module 5: Myocardial Toxicity
5.1. Incidence and Clinical Relevance: Frequency and impact in cancer patients.
Skills: Analyze incidence data; understand clinical relevance of myocardial toxicity.
5.2. Mechanisms of Myocardial Toxicity: Pathophysiology of myocardial damage.
Skills: Understand and explain the mechanisms of myocardial toxicity; apply knowledge to patient care.
5.3. Diagnostic Methods for Myocardial Toxicity: Diagnostic approaches and tools.
Skills: Utilize diagnostic tools for myocardial toxicity; implement diagnostic strategies.
5.4. Prevention and Treatment Strategies: Guidelines for managing myocardial toxicity.
Skills: Develop and apply prevention and treatment strategies; create guidelines for management.
5.5. Evaluation of Long-Term Cardiovascular Outcomes: Long-term effects and outcomes.
Skills: Evaluate long-term outcomes; integrate findings into patient management plans.
Module 6: Ischemic Heart Disease
6.1. Risk Factors for Ischemic Heart Disease in Cancer Patients: Identification of risk factors.
Skills: Identify and assess risk factors for ischemic heart disease in cancer patients.
6.2. Diagnostic Methods for Ischemic Heart Disease: Techniques for diagnosing ischemic heart disease.
Skills: Apply diagnostic techniques for ischemic heart disease; interpret diagnostic results.
6.3. Treatment and Management of Ischemic Heart Disease: Approaches for managing ischemic heart disease, including pharmacological and non-pharmacological interventions.
Skills: Develop treatment and management plans; integrate pharmacological and non-pharmacological approaches.
6.4. Prognostic Factors for Ischemic Heart Disease: Factors influencing prognosis and outcomes.
Skills: Assess and utilize prognostic factors; apply findings to patient care.
6.5. Case Studies in Ischemic Heart Disease: Analysis of real-life cases to illustrate the complexities of managing ischemic heart disease in the context of cancer treatment.
Skills: Analyze and learn from case studies; apply knowledge to clinical practice.
Module 7: Arrhythmias
7.1. Types of Arrhythmias Induced by Oncologic Treatments: Classification and understanding of arrhythmias resulting from cancer therapies.
Skills: Classify and understand different arrhythmias; apply knowledge to patient assessment.
7.2. Diagnostic Methods for Arrhythmias: Approaches and technologies for detecting and diagnosing arrhythmias.
Skills: Use diagnostic technologies for arrhythmia detection; interpret results.
7.3. Treatment and Management of Arrhythmias: Strategies for managing arrhythmias, including pharmacological and procedural interventions.
Skills: Develop and implement management strategies; apply pharmacological and procedural interventions.
7.4. Prognostic Factors for Arrhythmias: Evaluation of factors affecting the prognosis of arrhythmias.
Skills: Assess prognostic factors; integrate findings into treatment plans.
7.5. Case Studies in Arrhythmias: Examination of case studies to illustrate management challenges and solutions.
Skills: Analyze case studies; apply insights to clinical management.
Module 8: Valvular and Pericardial Diseases
8.1. Incidence and Clinical Relevance: Understanding the occurrence and impact of valvular and pericardial diseases in cancer patients.
Skills: Assess the incidence and clinical impact of these diseases; apply findings to patient care.
8.2. Diagnostic Methods for Valvular and Pericardial Diseases: Techniques for diagnosing these conditions.
Skills: Utilize diagnostic techniques for valvular and pericardial diseases; interpret results.
8.3. Treatment and Management of Valvular and Pericardial Diseases: Management approaches including surgical and non-surgical options.
Skills: Develop and implement treatment plans; integrate surgical and non-surgical options.
8.4. Prognostic Factors for Valvular and Pericardial Diseases: Assessment of factors influencing outcomes.
Skills: Evaluate prognostic factors; apply findings to clinical management.
8.5. Case Studies in Valvular and Pericardial Diseases: Real-life case studies demonstrating management challenges.
Skills: Analyze case studies; apply insights to clinical practice.
Module 9: Arterial Hypertension
9.1. Pathophysiology of Arterial Hypertension in Cancer Patients: Exploration of how cancer treatments contribute to arterial hypertension.
Skills: Understand and explain the pathophysiology; apply knowledge to patient management.
9.2. Diagnostic Methods for Arterial Hypertension: Methods and tools for diagnosing hypertension in the context of cancer therapy.
Skills: Utilize diagnostic tools for hypertension; interpret diagnostic results.
9.3. Treatment and Management of Arterial Hypertension: Strategies for controlling and managing hypertension.
Skills: Develop and implement management strategies; integrate treatment options.
9.4. Prognostic Factors for Arterial Hypertension: Factors affecting prognosis and management.
Skills: Assess prognostic factors; apply findings to patient care.
9.5. Case Studies in Arterial Hypertension: Examination of case studies illustrating management approaches.
Skills: Analyze case studies; apply insights to clinical management.
Module 10: Innovative Therapies and Monitoring Strategies
10.1. New Molecular Targets and Cardiotoxicity: Overview of emerging molecular targets and their implications.
Skills: Analyze the implications of new molecular targets; integrate findings into patient care.
10.2. Innovative Monitoring Strategies: Techniques and technologies for monitoring cardiovascular health.
Skills: Implement and utilize innovative monitoring strategies; interpret data for patient care.
10.3. Research and Future Directions: Exploration of current research and future trends in cardio-oncology.
Skills: Evaluate current research; anticipate future trends and their impact on practice.
10.4. Integrative Approaches: Integration of innovative therapies and monitoring strategies into clinical practice.
Skills: Develop and implement integrative approaches; apply innovative strategies in clinical settings.
10.5. Case Studies in Innovative Therapies: Analysis of case studies involving innovative approaches.
Skills: Analyze case studies; apply insights to clinical practice.
How to Join the Academy
Start Studying Immediately: No registration required; gain instant access.
Instant Access: Receive your username and password immediately after payment.
Enrollment Steps:
Complete Enrollment: After payment, receive your username and password. Log in to upload your MBBS degree and enter your name as per your passport.if the degree is found to be fake, your course will be canceled, and a refund will be processed within 5 days.
Start Your Studies: Access all course materials, interactive modules, and assignments via our online platform.
Complete the Program: Engage with the content, participate in discussions, and complete assignments.
Obtain Certification: Receive your Professional Master’s Degree in Cardio-Oncology. The certificate will be delivered to your residence free of charge, including international delivery. You can also download an e-certificate directly from your course page upon completion.
Refund Policy
We offer a 30-day refund policy. To request a refund:
Log In to Your Account: Use your credentials to access your account.
Navigate to Your Course Page: Locate your enrolled course.
Request Cancellation: Initiate the cancellation process directly from your course page.
Refund Processing: We will process your full refund within 5 days of cancellation.
NHS-UK -GMC UK
